Splash Beverage shares rise 12.0% intraday after announcing proposed merger with Medterra CBD.

Splash Beverage Group surged 12% intraday after announcing a non-binding letter of intent to merge with Medterra CBD, a federally compliant cannabinoid wellness company. The proposed deal, described as a “transformative step” by Splash, positions the firm to pivot toward a growth-oriented platform in regulated cannabinoid wellness and consumer health. The merger aligns with recent regulatory clarity, including President Trump’s executive order reclassifying medical marijuana and a CMS CBD pilot initiative, which could expand market opportunities for hemp-derived products. Medterra’s $52 million in 2025 revenue and established brand portfolio further underscore the strategic rationale. The transaction, pending approvals, would see Medterra’s CEO join Splash’s board, signaling a shift from beverage-focused operations to cannabinoid wellness. This strategic realignment, coupled with growing institutional interest in federally compliant CBD products, likely drove the sharp intraday rally.